SIREN : 512904129
OSTHEOPATHIE F.I is a French company founded 16 years ago, specialized in the sector Enseignement supérieur. Based in CLICHY (92110), this company of category ETI shows in 2025 a revenue of 14.8 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14 768 799 € | 14 540 721 € | 14 368 396 € | 14 132 271 € | 11 974 984 € | 10 354 160 € | 10 077 713 € | 9 000 418 € | 8 543 158 € | 8 220 728 € |
| Net income | 2 170 550 € | 2 269 244 € | 2 148 181 € | 1 254 759 € | 1 273 280 € | 779 432 € | 882 842 € | 889 538 € | 63 057 € | -142 247 € |
| EBITDA | 3 990 196 € | 3 579 558 € | 3 221 764 € | 3 135 595 € | 2 615 187 € | 1 983 166 € | 1 958 967 € | 1 750 337 € | 1 153 289 € | -417 577 € |
| Net margin | 14.7% | 15.6% | 15.0% | 8.9% | 10.6% | 7.5% | 8.8% | 9.9% | 0.7% | -1.7% |
In 2025, OSTHEOPATHIE F.I achieves revenue of 14.8 M€. Over the period 2016-2025, the company shows strong growth with a CAGR (compound annual growth rate) of +6.7%. Vs 2024: +2%. After deducting consumption (13 k€), gross margin stands at 14.8 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 4.0 M€, representing 27.0% of revenue. Positive scissor effect: EBITDA margin improves by +2.4 pts, sign of improved operational efficiency. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 2.2 M€, i.e. 14.7% of revenue. This profit can be retained or distributed to shareholders.
14 768 799 €
14 755 311 €
3 990 196 €
2 790 058 €
2 170 550 €
27.0%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 35%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.0 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 21.7% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
0.014%
34.956%
21.735%
0.001
26.5%
In 2025, the debt ratio of OSTHEOPATHIE F.I (0.01) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2025, the financial autonomy of OSTHEOPATHIE F.I (35.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2025, the repayment capacity of OSTHEOPATHIE F.I (0.00) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
The liquidity ratio (= Current assets / Current liabilities) stands at 139.21. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 10.1x. Operating income very largely covers interest expenses: high safety margin.
139.211
10.102
In 2025, the liquidity ratio of OSTHEOPATHIE F.I (139.21) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2025, the interest coverage of OSTHEOPATHIE F.I (10.1x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 16 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 179 days. Excellent situation: suppliers finance 163 days of the operating cycle (retail model). Overall, WCR represents 262 days of revenue, i.e. 10.8 M€ to permanently finance. Over 2016-2025, WCR increased by +270%, requiring additional financing.
10 764 830 €
16 j
179 j
0 j
262 j
Based on 412 transactions of similar company sales (all years), the value of OSTHEOPATHIE F.I is estimated at 8 861 082 € (range 3 563 834€ - 24 389 509€). With an EBITDA of 3 990 196€, the sector multiple of 3.0x is applied. The price/revenue ratio is 0.29x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 412 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare OSTHEOPATHIE F.I with other companies in the same sector:
Voir toutes les statistiques du secteur Enseignement supérieur
The revenue of OSTHEOPATHIE F.I in 2025 is 14.8 M€.
Yes, OSTHEOPATHIE F.I generated a net profit of 2.2 M€ in 2025.
The headquarters of OSTHEOPATHIE F.I is located in CLICHY (92110), in the department Hauts-de-Seine.
The tax return of OSTHEOPATHIE F.I is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
OSTHEOPATHIE F.I operates in the sector Enseignement supérieur (NAF code 85.42Z). See the 'Sector positioning' section above to compare the company with its competitors.